Breast, JZP598-208

ClinicalTrials.gov ID: NCT07102381

The purpose of this study is to see if zanidatamab is safe and effective, when combined with chemotherapy, in treating people who has Human Epidermal Growth Factor Receptor 2 (HER2)-positive, early-stage breast cancer.

 

Breast, A012303, Shortstop-HER2

ClinicalTrials.gov ID: NCT06876714

Making Healthy Choices - Slide

Cancer Q&A with HOA
Making Healthy Choices

Cancer Q&A with HOA: Making Healthy Choices

Cancer Q&A with HOA: Keeping Hope Alive Amidst a Cancer Diagnosis

Patient Newsletter 2025 December

Patient Newsletter 2025 November

What Every Woman Should Know About Lung Cancer

Pages